Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avivit Cahn

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Expert Opinion on Drug Safety|March 1, 2016
Saxagliptin for the treatment of diabetes - a focus on safetySimona Cernea, Avivit Cahn, Itamar Raz
Journal of Diabetes|November 23, 2019
SGLT2 inhibitors for primary prevention of cardiovascular eventsItamar Raz, Simona Cernea, Avivit Cahn
Annals of Translational Medicine|February 5, 2020
The SONAR study-is there a future for endothelin receptor antagonists in diabetic kidney disease?Avivit Cahn, Simona Cernea, Itamar Raz
Expert Review of Clinical Pharmacology|March 10, 2017
Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetesSimona Cernea, Avivit Cahn, Itamar Raz
Diabetes Care|July 22, 2016
Is the Use of DPP-4 Inhibitors Associated With an Increased Risk for Heart Failure? Lessons From EXAMINE, SAVOR-TIMI 53, and TECOSGuntram Schernthaner, Avivit Cahn, Itamar Raz
Expert Opinion on Emerging Drugs|November 5, 2016
An update on DPP-4 inhibitors in the management of type 2 diabetesAvivit Cahn, Simona Cernea, Itamar Raz
Diabetes/Metabolism Research and Reviews|January 22, 2014
Establishing a multidisciplinary diabetic foot team in a large tertiary hospital: a workshopAvivit Cahn, Ofer Elishuv, Keren Olshtain-Pops
Diabetes, Obesity & Metabolism|January 13, 2026
Risk of recurrent diabetic ketoacidosis following initiation of sodium-glucose co-transporter 2 inhibitors in patients with an insulin-deficient diabetes and prior diabetic ketoacidosis: An observational cohort studyAnat Tsur, Omer Hamtzany, Rena Pollack, et al.
The Israel Medical Association Journal : IMAJ|April 2, 2004
Identification of a novel mutation in the gene for bone morphogenetic protein receptor II in an Israeli patient with familial primary pulmonary hypertensionAvivit Cahn, Vardiella Meiner, Eran Leitersdorf, et al.
Diabetes, Obesity & Metabolism|March 14, 2025
Kidney outcomes with SGLT2 inhibitors in patients with diabetes and an insulin-deficient phenotype: A real world analysisAnat Tsur, Avivit Cahn, Lior Hanoch, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Expert Opinion on Drug Safety|March 1, 2016
Saxagliptin for the treatment of diabetes - a focus on safetySimona Cernea, Avivit Cahn, Itamar Raz
Journal of Diabetes|November 23, 2019
SGLT2 inhibitors for primary prevention of cardiovascular eventsItamar Raz, Simona Cernea, Avivit Cahn
Annals of Translational Medicine|February 5, 2020
The SONAR study-is there a future for endothelin receptor antagonists in diabetic kidney disease?Avivit Cahn, Simona Cernea, Itamar Raz
Expert Review of Clinical Pharmacology|March 10, 2017
Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetesSimona Cernea, Avivit Cahn, Itamar Raz
Diabetes Care|July 22, 2016
Is the Use of DPP-4 Inhibitors Associated With an Increased Risk for Heart Failure? Lessons From EXAMINE, SAVOR-TIMI 53, and TECOSGuntram Schernthaner, Avivit Cahn, Itamar Raz
Expert Opinion on Emerging Drugs|November 5, 2016
An update on DPP-4 inhibitors in the management of type 2 diabetesAvivit Cahn, Simona Cernea, Itamar Raz
Diabetes/Metabolism Research and Reviews|January 22, 2014
Establishing a multidisciplinary diabetic foot team in a large tertiary hospital: a workshopAvivit Cahn, Ofer Elishuv, Keren Olshtain-Pops
Diabetes, Obesity & Metabolism|January 13, 2026
Risk of recurrent diabetic ketoacidosis following initiation of sodium-glucose co-transporter 2 inhibitors in patients with an insulin-deficient diabetes and prior diabetic ketoacidosis: An observational cohort studyAnat Tsur, Omer Hamtzany, Rena Pollack, et al.
The Israel Medical Association Journal : IMAJ|April 2, 2004
Identification of a novel mutation in the gene for bone morphogenetic protein receptor II in an Israeli patient with familial primary pulmonary hypertensionAvivit Cahn, Vardiella Meiner, Eran Leitersdorf, et al.
Diabetes, Obesity & Metabolism|March 14, 2025
Kidney outcomes with SGLT2 inhibitors in patients with diabetes and an insulin-deficient phenotype: A real world analysisAnat Tsur, Avivit Cahn, Lior Hanoch, et al.
Pageof 11